Trials / Completed
CompletedNCT01694680
Intervention Trial in Early Age-related Macular Degeneration
Intervention Study to Assess the Effect of Daily Consumption of a Lutein-enriched-egg Beverage on Maintenance of Visual Function in Subjects With Early Signs of Age-related Macular Degeneration
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (actual)
- Sponsor
- Newtricious R&D BV · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the I-TEAM project is to assess whether there is a change in visual function and status of the retina after a year of intervention in subjects with early signs of Age-related Macular Degeneration.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Lutein-enriched-egg beverage (NWT-02) | Lutein, zeaxanthin and DHA-enriched-egg yolk combined with buttermilk beverage |
| DIETARY_SUPPLEMENT | Placebo | color-, taste- and energy-matched powder without enriched egg-yolk |
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2016-04-01
- Completion
- 2016-04-01
- First posted
- 2012-09-27
- Last updated
- 2016-09-21
Locations
4 sites across 4 countries: United States, Germany, Netherlands, United Kingdom
Source: ClinicalTrials.gov record NCT01694680. Inclusion in this directory is not an endorsement.